Q3 2025 Holdings
Filed 2025-11-14 | 25 holdings | $164.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $20.4M | 302,483 | 12.5% |
| Soleno Therapeutics Inc(SLNO)Call | COM | 834203309 | $16.9M | 250,000 | 10.3% |
| Replimune Group Inc(REPL)Call | COM | 76029N106 | $15.1M | 3,600,000 | 9.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $15.0M | 32,662 | 9.1% |
| Atai Beckley NV | SHS | N0731H103 | $12.1M | 2,287,005 | 7.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $10.2M | 51,080 | 6.2% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $8.2M | 175,363 | 5.0% |
| Compass Pathways PLC(CMPS)Call | SPONSORED ADS | 20451W101 | $6.6M | 1,145,700 | 4.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $6.2M | 1,898,112 | 3.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $5.9M | 437,391 | 3.6% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.9M | 1,026,382 | 3.6% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $5.4M | 915,000 | 3.3% |
| Praxis Precision Medicines I(PRAX)Call | COM NEW | 74006W207 | $5.3M | 100,000 | 3.2% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $5.3M | 64,455 | 3.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $4.4M | 233,220 | 2.7% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $4.3M | 361,444 | 2.6% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $4.2M | 70,778 | 2.6% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $3.4M | 549,182 | 2.1% |
| Promis Neurosciences Inc(PMNEUR) | COM NEW | 74346M406 | $2.6M | 6,233,497 | 1.6% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $2.3M | 178,100 | 1.4% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $2.2M | 138,595 | 1.3% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $1.6M | 817,939 | 0.9% |
| Moonlake Immunotherapeutics(MLTX)Call | CLASS A ORD | 61559X104 | $494.7K | 69,000 | 0.3% |
| Atyr Pharma Inc(ATYR)Call | COM NEW | 002120202 | $432.8K | 600,000 | 0.3% |